Alpha Cognition Inc. Contract Liability (Deferred Revenue)
Alpha Cognition Inc. (ACOG) had Contract Liability (Deferred Revenue) of $103.19 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Contract with Customer, Liability, Current $103.19K.
- 2026-03-31: Contract with Customer, Liability, Current $115.15K.
- 2025-12-31: Contract with Customer, Liability, Current $153.17K.
- 2025-03-31: Contract with Customer, Liability, Current $23.94K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $103.19K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $115.15K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $153.17K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $23.94K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |